Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
KT-333—a potent, extremely selective heterobifunctional small molecule STAT3 degrader—was effectively tolerated with primarily grade 1 and a pair of adversarial results (AEs) in...
Hope for histotripsy
“Histotripsy makes use of acoustic power, or sound waves, to switch tissue,” mentioned Rossmeisl. “The intent is to trigger a mechanical...
